Literature DB >> 18951621

Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis.

Sébastien Conus, Alex Straumann, Hans-Uwe Simon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951621     DOI: 10.1016/j.jaci.2008.09.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Recent advances in the treatment of eosinophilic esophagitis.

Authors:  Shauna Schroeder; Dan Atkins; Glenn T Furuta
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

Review 2.  Non- and semi-invasive methods of monitoring eosinophilic esophagitis.

Authors:  Calies Menard-Katcher; Glenn T Furuta
Journal:  Dig Dis       Date:  2014-02-28       Impact factor: 2.404

Review 3.  Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.

Authors:  Mahsa Eskian; MirHojjat Khorasanizadeh; Amal H Assa'ad; Nima Rezaei
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

4.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Authors:  Elizabeth A Kelly; Stephane Esnault; Lin Ying Liu; Michael D Evans; Mats W Johansson; Sameer Mathur; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

5.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

6.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

Review 7.  Eosinophilic Esophagitis and Gastroenteritis.

Authors:  Antonella Cianferoni; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2015-09       Impact factor: 4.806

Review 8.  Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications.

Authors:  Melanie A Ruffner; Katie Kennedy; Antonella Cianferoni
Journal:  Expert Rev Clin Immunol       Date:  2018-11-19       Impact factor: 5.124

Review 9.  Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview.

Authors:  M Hassani; L Koenderman
Journal:  Allergy       Date:  2018-10-08       Impact factor: 13.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.